$康方生物(09926)$ Summit Therapeutics - Received & Accepted Unsolicited Offer From Institutional Investor to Purchase 22.2 Mln Shares of Co's Common Stock at $9.00 per Share

Summit Therapeutics - 收到并接受来自机构投资者的自愿要约，以每股9.00美元的价格购买公司的2220万股普通股。

summit定增融了两亿刀，9美元价格，比现价高一点